|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$126,276
|
N/A
|
National Institutes of Health
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,161,432
|
$0
|
N/A
|
DCEG (NCI)
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$12,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$6,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$11,865
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$19,954
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$379,272
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Master Regulatory MicroRNAs in Glioblastoma
|
1U01CA220841-01
|
$466,876
|
$466,876
|
ABOUNADER, ROGER
|
UNIVERSITY OF VIRGINIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-04S1
|
$1,393,520
|
$313,542
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-04
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-04
|
$22,547,116
|
$5,073,101
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-03S1
|
$154,939
|
$15,494
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-04
|
$737,200
|
$73,720
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Serum metabolomic profiling of glioma risk in the PLCO study
|
ZIA CP010152-10792
|
$114,839
|
$114,839
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-04
|
$1,367,856
|
$205,178
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Treatment of glioma with nanocombretastatin with MRI monitoring
|
5R01CA206190-02
|
$342,554
|
$342,554
|
ALI, MESER
|
Henry Ford Health System
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
|
5P01CA196539-03
|
$1,855,117
|
$1,855,117
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
|
5U01CA202144-03
|
$704,509
|
$352,255
|
ALTER, ORLY
|
UNIVERSITY OF UTAH
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$2,383,555
|
$23,836
|
Alter, Blanche
|
DCEG (NCI)
|
|
Discovery of Novel Therapeutics for Glioblastoma
|
1R43CA213695-01A1
|
$300,000
|
$300,000
|
ALTON, GORDON
|
CURTANA PHARMACEUTICALS, INC.
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$37,792
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
A clone's genomic stability as biomarker of its DNA-damage resilience
|
1K99CA215256-01
|
$166,644
|
$166,644
|
ANDOR, NOEMI
|
STANFORD UNIVERSITY
|
|
Development of whole-brain in vivo 2HG imaging for precision medicine in mutant IDH glioma
|
1R01CA211080-01
|
$616,246
|
$616,246
|
ANDRONESI, OVIDIU
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-04
|
$637,150
|
$31,858
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Natural History and Specimen Banking for Patients with CNS Tumors
|
ZIA BC 011768
|
$548,393
|
$548,393
|
Armstrong, Terri
|
CCR (NCI)
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-08S1
|
$175,000
|
$10,500
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
$148,800
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
$947,156
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
$17,500
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
$8,400
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
2R01CA155769-06A1
|
$410,877
|
$410,877
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Identifying vulnerabilities and therapeutic targets in Glioma Stem Cells
|
5K22CA197053-03
|
$200,880
|
$200,880
|
BADR, CHRISTIAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$1,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$318
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$42,885
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Normal and Neoplastic Growth in the Brain
|
5P01CA096832-13
|
$2,039,886
|
$2,039,886
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cooperating Pathways in Gliomagenesis
|
5R01CA188516-04
|
$372,463
|
$372,463
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
|
5R35CA197684-02
|
$848,325
|
$212,081
|
BALDWIN, ALBERT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Characterizing the resistance mechanisms to BET-bromodomain inhibition in MYC-amplified medulloblastoma
|
5K99CA201592-02
|
$151,039
|
$151,039
|
BANDOPADHAYAY, PRATITI
|
DANA-FARBER CANCER INST
|
|
Targeting Ferritin in Glioblastoma
|
5R01CA169117-05
|
$532,477
|
$532,477
|
BAO, SHIDENG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
|
5R01CA184090-03
|
$362,569
|
$362,569
|
BAO, SHIDENG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
|
5R01CA187780-03
|
$385,491
|
$385,491
|
BAR, ELI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-03
|
$332,363
|
$132,945
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$218,891
|
$21,889
|
Barr, Frederic
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$98,501
|
Barr, Frederic
|
CCR (NCI)
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-04
|
$1,316,888
|
$65,844
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Angiogenesis-targeting therapy for glioblastoma
|
3R01CA129371-10S1
|
$251,370
|
$251,370
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Training Program in Nervous System Tumors
|
5K12CA090354-17
|
$805,200
|
$805,200
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
SPORE: Targeted Therapies for Glioma
|
5P50CA165962-05
|
$2,280,112
|
$2,280,112
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Angiogenesis-targeting therapy for glioblastoma
|
5R01CA129371-10
|
$592,913
|
$592,913
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
Total relevant funding to Brain for this search: $216,979,499
|